Autophagy as an emerging therapy target for ovarian carcinoma

Lei Zhan; Yu Zhang; Wenyan Wang; Enxue Song; Yijun Fan; Jun Li; Bing Wei

doi:10.18632/oncotarget.13080

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Autophagy as an emerging therapy target for ovarian carcinoma

Lei Zhan _, Yu Zhang, Wenyan Wang, Enxue Song, Yijun Fan, Jun Li and Bing Wei

PDF | HTML | How to cite

Oncotarget. 2016; 7:83476-83487. https://doi.org/10.18632/oncotarget.13080

Metrics: PDF 2751 views | HTML 3100 views | ?

Abstract

Lei Zhan1, Yu Zhang1, Wenyan Wang1, Enxue Song1, Yijun Fan1, Jun Li2,*, Bing Wei1

1Department of gynecology and obstetrics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China

2School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China

*Co-corresponding author

Correspondence to:

Bing Wei, email: [email protected], [email protected]

Keywords: autophagy, dual functions, ovarian carcinoma, mechanism, therapies

Received: June 21, 2016 Accepted: September 21, 2016 Published: November 04, 2016

ABSTRACT

Autophagy is a conserved cellular self-digestion pathway for maintenance of homeostasis under basal and stressed conditions. Autophagy plays pivotal roles in the pathogenesis of many diseases, such as aging-related diseases, autoimmune diseases, cardiovascular diseases, and cancers. Of special note is that accumulating data suggest an intimate relationship between autophagy and ovarian carcinoma. Autophagy is well identified to act as either as a tumor-suppressor or as a tumor-promoter in ovarian carcinoma. The exact function of autophagy in ovarian carcinoma is highly dependent on the circumstances of cancer including hypoxic, nutrient-deficient, chemotherapy and so on. However, the mechanism underlying autophagy associated with ovarian carcinoma remains elusive, the precise role of autophagy in ovarian carcinoma also remains undetermined. In this review, we tried to sum up and discuss recent research achievements of autophagy in ovarian cancer. Moreover, waves of novel therapies ways for ovarian carcinoma based on the functions of autophagy were collected.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 13080

Publication Alerts

Research Papers:

Autophagy as an emerging therapy target for ovarian carcinoma

Abstract